1
|
Lee JC, Tran QT, McGee RB, Perrino MR, Upadhyaya SA, Hanzlik EM, Pytel N, Carroll AJ, Orisme W, Eldomery M, Wang L, Blackburn PR, Furtado LV, Viaene AN, Luo M, Kalish JM, Pinto SN, Bag AK, Orr BA. Atypical teratoid/rhabdoid tumour-TYR subtype arising in the setting of germline ring chromosome 22: An uncommon form of tumour predisposition. Neuropathol Appl Neurobiol 2024; 50:e12971. [PMID: 38488196 DOI: 10.1111/nan.12971] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2023] [Revised: 02/12/2024] [Accepted: 02/28/2024] [Indexed: 03/19/2024]
Affiliation(s)
- Julieann C Lee
- Department of Pathology, Neuropathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA
| | - Quynh T Tran
- Department of Pathology, Neuropathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA
| | - Rose B McGee
- Department of Oncology, Division of Cancer Predisposition, St. Jude Children's Research Hospital, Memphis, Tennessee, USA
| | - Melissa R Perrino
- Department of Oncology, Division of Cancer Predisposition, St. Jude Children's Research Hospital, Memphis, Tennessee, USA
| | - Santhosh A Upadhyaya
- Department of Pediatrics and Communicable Diseases, C. S. Mott Children's Hospital, University of Michigan, Ann Arbor, Michigan, USA
| | - Emily M Hanzlik
- Department of Pediatrics, Division of Neuro-Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA
| | - Nicholas Pytel
- Department of Pediatrics, Division of Neuro-Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA
| | - Andrew J Carroll
- Department of Genetics, University of Alabama, Birmingham, Alabama, USA
| | - Wilda Orisme
- Department of Pathology, Neuropathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA
| | - Mohammad Eldomery
- Department of Pathology, Molecular Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA
| | - Lu Wang
- Department of Pathology, Molecular Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA
| | - Patrick R Blackburn
- Department of Pathology, Molecular Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA
| | - Larissa V Furtado
- Department of Pathology, Molecular Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA
| | - Angela N Viaene
- Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
| | - Minjie Luo
- Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
| | - Jennifer M Kalish
- Division of Human Genetics and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA
- Departments of Genetics and Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Soniya N Pinto
- Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis, Tennessee, USA
| | - Asim K Bag
- Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis, Tennessee, USA
| | - Brent A Orr
- Department of Pathology, Neuropathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA
| |
Collapse
|
2
|
Pytel N, Dedekam E, Salamat MS, Puccetti D. RARE-41. SECOND MALIGNANCIES FOLLOWING TREATMENT FOR PRIMARY CENTRAL NERVOUS SYSTEM TUMORS IN PEDIATRIC PATIENTS: A SINGLE-INSTITUTIONAL RETROSPECTIVE REVIEW. Neuro Oncol 2020. [PMCID: PMC7715371 DOI: 10.1093/neuonc/noaa222.751] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
Abstract
Second malignant neoplasms following treatment for primary central nervous system (CNS) tumors in children are rare occurrences but may often have dire consequences, particularly, if thought to be induced by prior therapies. The authors retrospectively reviewed pediatric patients with primary CNS malignancies from the University of Wisconsin over the last 25 years (1994 – 2019) with any secondary malignant neoplasm and determined seven patients met criteria. Treatment modalities were reviewed with all patients receiving surgery, chemotherapy, and radiotherapy for treatment of their first malignancy. The second neoplasms found included 4 high-grade gliomas, 1 meningioma, 1 thyroid carcinoma, and 1 myelodysplastic syndrome. The median latency time between diagnoses was 9 years (range 4 -17 years). The outcomes varied according to histopathology of the second neoplasm with the high-grade glioma patients all deceased from progressive disease. The high-grade gliomas were thought to have been induced by prior radiation in most cases. The remaining patients are still alive, at the time of this writing, and in follow up after treatment for their second neoplasm. Thus, long-term follow up is essential for children treated for a primary CNS tumor given the variety of second neoplasms that could arise with differential consequences. In addition to our single institutional outcomes, we will also present an updated review of the literature of pediatric patients with primary CNS tumors and second malignancies.
Collapse
|
3
|
Pytel N, Dedekam E, Salamat SM, Puccetti D. NCMP-22. SECOND MALIGNANCIES FOLLOWING TREATMENT FOR PRIMARY CENTRAL NERVOUS SYSTEM TUMORS IN PEDIATRIC PATIENTS: A SINGLE-INSTITUTIONAL RETROSPECTIVE REVIEW. Neuro Oncol 2020. [DOI: 10.1093/neuonc/noaa215.533] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Second malignant neoplasms following treatment for primary central nervous system (CNS) tumors in children are rare occurrences but may often have dire consequences, particularly, if thought to be induced by prior therapies. The authors retrospectively reviewed pediatric patients with primary CNS malignancies from the University of Wisconsin over the last 25 years (1994 – 2019) with any secondary malignant neoplasm and determined seven patients met criteria. Treatment modalities were reviewed with all patients receiving surgery, chemotherapy, and radiotherapy for treatment of their first malignancy. The second neoplasms found included 4 high-grade gliomas, 1 meningioma, 1 thyroid carcinoma, and 1 myelodysplastic syndrome. The median latency time between diagnoses was 9 years (range 4 -17 years). The outcomes varied according to histopathology of the second neoplasm with the high-grade glioma patients all deceased from progressive disease. The high-grade gliomas were thought to have been induced by prior radiation in most cases. The remaining patients are still alive, at the time of this writing, and in follow up after treatment for their second neoplasm. Thus, long-term follow up is essential for children treated for a primary CNS tumor given the variety of second neoplasms that could arise with differential consequences. In addition to our single institutional outcomes, we will also present an updated review of the literature of pediatric patients with primary CNS tumors and second malignancies.
Collapse
Affiliation(s)
- Nicholas Pytel
- American Family Children’s Hospital, University of Wisconsin-Madison, Madison, WI, USA
| | - Erik Dedekam
- Department of Radiology, University of Wisconsin - Madison, Madison, WI, USA
| | - Shahriar M Salamat
- Department of Pathology, University of Wisconsin - Madison, Madison, WI, USA
| | - Diane Puccetti
- American Family Children’s Hospital, University of Wisconsin-Madison, Madison, WI, USA
| |
Collapse
|
4
|
Pytel N, Harn N, Salamat SM, Bradley K, Ahmed R, Iskandar B, Puccetti D. RADI-11. THREE CASES OF CLINICALLY SUSPECTED CAVERNOMAS FOUND TO HAVE VERY DIFFERENT PATHOLOGIES. Neuro Oncol 2018. [DOI: 10.1093/neuonc/noy059.651] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- Nicholas Pytel
- University of Wisconsin - Dept of Pediatrics, Madison, WI, USA
| | - Nicholas Harn
- University of Wisconsin - Dept of Radiology, Madison, WI, USA
| | | | - Kristin Bradley
- University of Wisconsin - Dept of Human Oncology, Madison, WI, USA
| | - Raheel Ahmed
- University of Wisconsin - Dept of Neurological Surgery, Madison, WI, USA
| | - Bermans Iskandar
- University of Wisconsin - Dept of Neurological Surgery, Madison, WI, USA
| | - Diane Puccetti
- University of Wisconsin - Dept of Pediatrics, Madison, WI, USA
| |
Collapse
|
5
|
Pytel N, Bashir M, Salamat S, Lulla R, Patel N, Puccetti D. MB-21CASE REPORT OF THE NATURAL HISTORY OF INCIDENTALLY FOUND MEDULLOBLASTOMA FOLLOWED RADIOGRAPHICALLY IN A YOUNG ADULT WITH CHRONIC HEADACHES. Neuro Oncol 2016. [DOI: 10.1093/neuonc/now076.19] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|